Supernus Pharmaceuticals (SUPN) Receivables - Other (2012 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Receivables - Other of $4.3 million for Q2 2026, down 20.37% year-over-year from $5.4 million in Q2 2025, and up 126.32% on a QoQ basis from $1.9 million in Q1 2026.
Supernus Pharmaceuticals (SUPN) Receivables - Other (2012 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Receivables - Other for 6 years, with the latest figure at $4.3 million in Q2 2026.
- Receivables - Other for Q2 2026 came in at $4.3 million, down 20.37% year-over-year; the trailing twelve-month figure through Jun 2026 was $4.3 million (down 20.37% YoY), and the FY2025 annual result was $1.8 million, down 55.0% from the prior year.
- Receivables - Other improved to $4.3 million in Q2 2026, from $1.9 million in the prior quarter.
- Over five years, Receivables - Other peaked at $6.3 million in Q3 2025 and troughed at $1.8 million in Q4 2025.
- A 3-year average of $4.0 million and a median of $4.1 million in 2024 frame the typical range for Receivables - Other.
- The widest annual swing landed in 2025, when Receivables - Other tumbled 55.0%; it then declined 20.37% in 2026.
- A 3-year view of Receivables - Other shows it stood at $4.0 million in 2024, then tumbled by 55.0% to $1.8 million in 2025, then soared by 138.89% to $4.3 million in 2026.
- Per Business Quant data, the three most recent Receivables - Other figures were $4.3 million in Q2 2026, $1.9 million in Q1 2026, and $1.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.30 Mn |
| Jun 30, 2026 | 4.30 Mn |
| Mar 31, 2026 | 1.90 Mn |
| Mar 31, 2026 | 1.90 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 6.30 Mn |
| Sep 30, 2025 | 6.30 Mn |
| Jun 30, 2025 | 5.40 Mn |
| Jun 30, 2025 | 5.40 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2014 | 493,000.00 |
| Sep 30, 2014 | 493,000.00 |
| Jun 30, 2014 | 496,000.00 |
| Jun 30, 2014 | 496,000.00 |
| Mar 31, 2014 | 636,000.00 |
| Mar 31, 2014 | 636,000.00 |
| Dec 31, 2013 | 483,000.00 |
| Dec 31, 2013 | 483,000.00 |